Document:

EX-10.2

 EXHIBIT 10.2 
 MORGAN STANLEY SCHEDULE OF NON-EMPLOYEE DIRECTORS ANNUAL
COMPENSATION 
 Effective as of August 1, 2014 

 

					
	 RETAINER(1)
	  	AMOUNT	 
	 Service as a Director
	  	$	75,000	  
	 Service as Chair of Audit Committee
	  	$	25,000	  
	 Service as Chair of Compensation, Management Development and Succession Committee; Nominating and Governance Committee; Risk
Committee; or Operations and Technology Committee
	  	$	20,000	  
	 Service as Member of Audit Committee, Compensation, Management Development and Succession Committee; Nominating and Governance
Committee; Operations and Technology Committee; or Risk Committee
	  	$	10,000	  
	 Service as Lead Director
	  	$	30,000	  

  

	(1) 	 The retainer shall be paid semi-annually in arrears for the period from the immediately preceding Annual Meeting of Shareholders until the next
succeeding Annual Meeting of Shareholders. 50% of a non-employee director’s retainer shall be made on (or promptly after) the business day coincident with or first following the six month anniversary of the immediately preceding Annual Meeting
of Shareholders. The remaining portion of a non-employee director’s retainer shall be made on (or promptly after) the next succeeding Annual Meeting of Shareholders. 

In the event a non-employee director joins the Board at a time other than an Annual Meeting of Shareholders, or commences service on an
additional Board committee, such director shall be entitled to receive a prorated retainer for service on the Board or such Board committee, as applicable, until the next succeeding Annual Meeting of Shareholders semi-annually in arrears. Such
retainer shall be prorated for service during the period beginning on the first day of the calendar month during which the non-employee director joins the Board, or commences service on such Board committee, until the last day of the calendar month
immediately preceding the calendar month during which the retainer is payable in accordance with the payment schedule set forth in the immediately preceding paragraph. 
 In the event a non-employee director terminates from service on the Board, or terminates from service on a Board committee, at a time other than an Annual Meeting of Shareholders, such director shall be
entitled to receive a prorated retainer for service on the Board and/or any such Board committee. Such retainer shall be prorated for service during the period beginning on the first day of the calendar month during which the last retainer payment
date occurs until the last day of the calendar month immediately preceding the calendar month during which the director’s Board and/or Board committee service termination date occurs and shall be made on (or promptly after) the director’s
Board and/or Board committee service termination date. 
 Notwithstanding the foregoing, a non-employee director may elect to
receive all or a portion of the retainer on a deferred basis under the Directors’ Equity Capital Accumulation Plan.Exhibit 10.6(c)

 

NEVRO CORP.

 

SECOND AMENDMENT TO

AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT

 

This Second Amendment to Amended and Restated Registration Rights Agreement (this “Second Amendment”), by and among Nevro Corp., a Delaware corporation (the “Company”), and the undersigned stockholders of the Company is made and entered into as of October 24, 2014, with respect to that certain Amended and Restated Registration Rights Agreement, dated as of February 8, 2013, as amended on March 5, 2013, by and among the Company and each of the stockholders of the Company listed on Exhibit A thereto, as such Exhibit A may be amended from time to time (the “Stockholders”) (as previously amended, the “Original Agreement”).  Capitalized terms used in this Second Amendment and not otherwise defined shall have the meaning ascribed to them in the Original Agreement.

 

RECITALS

 

WHEREAS, the Company and the undersigned Stockholders desire to amend the Original Agreement in certain respects as set forth herein.

 

WHEREAS, pursuant to Section 14.3 of the Original Agreement, the provisions of the Original Agreement may be amended or waived at any time by the written agreement of the Company and Stockholders holding at least 70% of the Registrable Securities.

 

WHEREAS, any amendment or waiver effected in accordance with Section 14.3 of the Original Agreement shall be binding upon each holder of Registrable Securities and the Company.

 

WHEREAS, the undersigned Stockholders hold, in the aggregate, not less than 70% of the Registrable Securities, voting together as a single class on an as-converted basis.

 

AGREEMENT

 

NOW, THEREFORE, in consideration of the recitals and the mutual premises, covenants and agreements contained herein and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto hereby agree as follows:

 

1.             Amendments.

 

(A).         The definition of “Qualified IPO” in Section 1 of the Original Agreement is hereby amended to read as follows:

 

“Qualified IPO” means a firm commitment underwritten public offering of Common Stock of the Company that yields net proceeds to the Company of not less than $50,000,000 (before deduction of underwriters commissions and expenses); provided, however, that if such offering is consummated after March 31, 2015, such offering must also be at an equivalent price per share of Common Stock of not less than 2.5 times the

 

 

Series C Original Issue Price (as adjusted for any equity split, equity combination, in-kind equity distribution, recapitalization or similar transaction).

 

2.             Reference to and Effect on the Original Agreement.  On or after the date hereof, each reference in the Original Agreement to “this Agreement,” “hereunder,” “herein” or words of like import shall mean and be a reference to the Original Agreement as amended hereby.  No reference to this Second Amendment need be made in any instrument or document at any time referring to the Original Agreement, a reference to the Agreement, in any of such to be deemed a reference to the Original Agreement as amended hereby.

 

3.             No Other Amendments.  Except as set forth herein, the Original Agreement shall remain in full force and effect in accordance with its terms.

 

4.             Counterparts.  This Second Amendment may be executed in any number of counterparts, each of which may be executed by less than all of the parties necessary to give effect to this Second Amendment, each of which shall be enforceable against the parties actually executing such counterparts, and all of which together shall constitute one instrument.

 

5.             Headings.  All section headings herein are inserted for convenience only and shall not modify or affect the construction or interpretation of any provisions of this Second Amendment or the Original Agreement.

 

6.             Governing Law.  This Second Amendment and all acts and transactions pursuant hereto and the rights and obligations of the parties hereto shall be governed, construed and interpreted in accordance with the laws of the State of California, without giving effect to principles of conflicts of law.

 

(Signature Pages Follow)

 

2

 

IN WITNESS WHEREOF, the parties hereto have duly executed this Second Amendment as of the date first above written.

 

 

	
 
    	
 
    	
NEVRO   CORP.
    
	
 
    	
 
    	
 
    
	
 
    	
 
    	
 
    
	
 
    	
 
    	
By:
    	
/s/   Michael DeMane
    
	
 
    	
 
    	
 
    	
Name:
    	
Michael   DeMane
    
	
 
    	
 
    	
 
    	
Title:
    	
Chief   Executive Officer
    

 

SIGNATURE PAGE TO NEVRO CORP.

SECOND AMENDMENT TO AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT

 

 

IN WITNESS WHEREOF, the parties hereto have duly executed this Second Amendment as of the date first above written.

 

 

	
 
    	
 
    	
NOVO   A/S
    
	
 
    	
 
    	
 
    
	
 
    	
 
    	
 
    
	
 
    	
 
    	
By:
    	
/s/   Thomas Dyrberg MD
    
	
 
    	
 
    	
 
    	
Name:
    	
Thomas   Dyrberg MD
    
	
 
    	
 
    	
 
    	
Title:
    	
Senior   Partner
    
	
 
    	
 
    	
 
    	
 
    	
 
    
	
 
    	
 
    	
 
    	
 
    	
 
    
	
 
    	
 
    	
Address:
    	
Novo   Ventures
    
	
 
    	
 
    	
 
    	
Tuborg   Havnevej 19
    
	
 
    	
 
    	
 
    	
DK-2900   Hellerup
    
	
 
    	
 
    	
 
    	
Denmark
    

 

SIGNATURE PAGE TO NEVRO CORP.

SECOND AMENDMENT TO AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT

 

 

IN WITNESS WHEREOF, the parties hereto have duly executed this Second Amendment as of the date first above written.

 

 

	
 
    	
 
    	
JOHNSON &   JOHNSON DEVELOPMENT CORPORATION
    
	
 
    	
 
    	
 
    
	
 
    	
 
    	
 
    
	
 
    	
 
    	
 
    	
By:
    	
/s/   Michael P. Chuisano
    
	
 
    	
 
    	
 
    	
Name:
    	
Michael   P. Chuisano
    
	
 
    	
 
    	
 
    	
Title:
    	
Vice   President and COO
    
	
 
    	
 
    	
 
    
	
 
    	
 
    	
 
    	
 
    
	
 
    	
 
    	
Address:
    	
410   George St.
    
	
 
    	
 
    	
 
    	
New   Brunswick, NJ 08901
    
	
 
    	
 
    	
 
    	
 
    
	
 
    	
 
    	
 
    	
 
    
	
 
    	
 
    	
With   a Copy to:
    	
Assistant   General Counsel
    
	
 
    	
 
    	
 
    	
One   Johnson & Johnson Plaza
    
	
 
    	
 
    	
 
    	
New   Brunswick, NJ 08933
    
						

 

SIGNATURE PAGE TO NEVRO CORP.

SECOND AMENDMENT TO AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT

 

 

IN WITNESS WHEREOF, the parties hereto have duly executed this Second Amendment as of the date first above written.

 

 

	
 
    	
 
    	
ABERDARE   VENTURES III, LP
    
	
 
    	
 
    	
By:
    	
Aberdare   GP III, LLC
    
	
 
    	
 
    	
Its:
    	
General   Partner
    
	
 
    	
 
    	
 
    
	
 
    	
 
    	
 
    
	
 
    	
 
    	
 
    	
By:
    	
/s/   John H. Odden
    
	
 
    	
 
    	
 
    	
Name:
    	
John   H. Odden
    
	
 
    	
 
    	
 
    	
Title:
    	
Manager
    
	
 
    	
 
    	
 
    
	
 
    	
 
    	
 
    
	
 
    	
 
    	
ABERDARE   PARTNERS III, LP
    
	
 
    	
 
    	
By:
    	
Aberdare   GP III, LLC
    
	
 
    	
 
    	
Its:
    	
General   Partner
    
	
 
    	
 
    	
 
    
	
 
    	
 
    	
 
    
	
 
    	
 
    	
 
    	
By:
    	
/s/   John H. Odden
    
	
 
    	
 
    	
 
    	
Name:
    	
John   H. Odden
    
	
 
    	
 
    	
 
    	
Title:
    	
Manager
    

 

SIGNATURE PAGE TO NEVRO CORP.

SECOND AMENDMENT TO AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT

 

 

IN WITNESS WHEREOF, the parties hereto have duly executed this Second Amendment as of the date first above written.

 

 

	
 
    	
 
    	
BAY   CITY CAPITAL FUND IV, L.P.
    
	
 
    	
 
    	
By:
    	
Bay   City Capital Management IV LLC
    
	
 
    	
 
    	
Its:
    	
General   Partner
    
	
 
    	
 
    	
By:
    	
Bay   City Capital LLC
    
	
 
    	
 
    	
Its:
    	
Manager
    
	
 
    	
 
    	
 
    
	
 
    	
 
    	
 
    
	
 
    	
 
    	
 
    	
By:
    	
/s/   Carl Goldfischer, MD
    
	
 
    	
 
    	
 
    	
Name:
    	
Carl   Goldfischer, MD
    
	
 
    	
 
    	
 
    	
Title:
    	
Manager   and Managing Director
    
	
 
    	
 
    	
 
    
	
 
    	
 
    	
 
    
	
 
    	
 
    	
BAY   CITY CAPITAL FUND IV
    
	
 
    	
 
    	
CO-INVESTMENT   FUND, L.P.
    
	
 
    	
 
    	
By:
    	
Bay   City Capital Management IV LLC
    
	
 
    	
 
    	
Its:
    	
General   Partner
    
	
 
    	
 
    	
By:
    	
Bay   City Capital LLC
    
	
 
    	
 
    	
Its:
    	
Manager
    
	
 
    	
 
    	
 
    
	
 
    	
 
    	
 
    
	
 
    	
 
    	
 
    	
By:
    	
/s/   Carl Goldfischer, MD
    
	
 
    	
 
    	
 
    	
Name:
    	
Carl   Goldfischer, MD
    
	
 
    	
 
    	
 
    	
Title:
    	
Manager   and Managing Director
    

 

SIGNATURE PAGE TO NEVRO CORP.

SECOND AMENDMENT TO AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT

 

 

IN WITNESS WHEREOF, the parties hereto have duly executed this Second Amendment as of the date first above written.

 

 

	
 
    	
 
    	
THREE   ARCH PARTNERS IV, L.P.
    
	
 
    	
 
    	
By:
    	
Three   Arch Management IV, L.L.C.
    
	
 
    	
 
    	
Its:
    	
General   Partner
    
	
 
    	
 
    	
 
    
	
 
    	
 
    	
 
    
	
 
    	
 
    	
 
    	
By:
    	
/s/   Wilfred Jaeger
    
	
 
    	
 
    	
 
    	
Name:
    	
Wilfred   Jaeger
    
	
 
    	
 
    	
 
    	
Title:
    	
Managing   Member
    
	
 
    	
 
    	
 
    
	
 
    	
 
    	
 
    
	
 
    	
 
    	
THREE   ARCH ASSOCIATES IV, L.P.
    
	
 
    	
 
    	
By:
    	
Three   Arch Management IV, L.L.C.
    
	
 
    	
 
    	
Its:
    	
General   Partner
    
	
 
    	
 
    	
 
    
	
 
    	
 
    	
 
    
	
 
    	
 
    	
 
    	
By:
    	
/s/   Wilfred Jaeger
    
	
 
    	
 
    	
 
    	
Name:
    	
Wilfred   Jaeger
    
	
 
    	
 
    	
 
    	
Title:
    	
Managing   Member
    

 

SIGNATURE PAGE TO NEVRO CORP.

SECOND AMENDMENT TO AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT

 

 

IN WITNESS WHEREOF, the parties hereto have duly executed this Second Amendment as of the date first above written.

 

 

	
 
    	
 
    	
MPM BIOVENTURES IV-QP, L.P.
    
	
 
    	
 
    	
By:
    	
MPM   BIOVENTURES IV GP LLC, its
    
	
 
    	
 
    	
General   Partner
    
	
 
    	
 
    	
 
    	
 
    
	
 
    	
 
    	
By:
    	
MPM   BIOVENTURES IV LLC, its 
    
	
 
    	
 
    	
Managing   Member
    
	
 
    	
 
    	
 
    
	
 
    	
 
    	
 
    
	
 
    	
 
    	
By:
    	
/s/   James Scopa
    
	
 
    	
 
    	
Name:
    	
James   Scopa
    
	
 
    	
 
    	
Title:
    	
Member
    
	
 
    	
 
    	
 
    
	
 
    	
 
    	
 
    
	
 
    	
 
    	
MPM   BIOVENTURES IV GMBH & CO.
   BETEILIGUNGS KG
    
	
 
    	
 
    	
By:
    	
MPM   BIOVENTURES IV GP LLC, in its
    
	
 
    	
 
    	
capacity   as the Managing Limited Partner
    
	
 
    	
 
    	
 
    
	
 
    	
 
    	
By:
    	
MPM   BIOVENTURES IV LLC, its 
    
	
 
    	
 
    	
Managing   Member
    
	
 
    	
 
    	
 
    
	
 
    	
 
    	
 
    
	
 
    	
 
    	
By:
    	
/s/   James Scopa
    
	
 
    	
 
    	
Name:
    	
James   Scopa
    
	
 
    	
 
    	
Title:
    	
Member
    
	
 
    	
 
    	
 
    
	
 
    	
 
    	
 
    
	
 
    	
 
    	
MPM   ASSET MANAGEMENT
   INVESTORS BV4 LLC
    
					

 

	
 
    	
 
    	
By:
    	
MPM   BIOVENTURES IV LLC, its 
    
	
 
    	
 
    	
Manager
    
	
 
    	
 
    	
 
    
	
 
    	
 
    	
 
    
	
 
    	
 
    	
By:
    	
/s/   James Scopa
    
	
 
    	
 
    	
Name:
    	
James   Scopa
    
	
 
    	
 
    	
Title:
    	
Member
    
					

 

SIGNATURE PAGE TO NEVRO CORP.

SECOND AMENDMENT TO AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT

 

 

IN WITNESS WHEREOF, the parties hereto have duly executed this Second Amendment as of the date first above written.

 

 

	
 
    	
 
    	
AMV   PARTNERS II, L.P.
    
	
 
    	
 
    	
By:
    	
Accuitive   Medical Ventures II, LLC
    
	
 
    	
 
    	
Its:
    	
General   Partner
    
	
 
    	
 
    	
 
    
	
 
    	
 
    	
 
    
	
 
    	
 
    	
 
    	
By:
    	
/s/   Gordon T. Wyatt
    
	
 
    	
 
    	
 
    	
Name:
    	
Gordon   T. Wyatt
    
	
 
    	
 
    	
 
    	
Title:
    	
Managing   Member/CFO
    

 

SIGNATURE PAGE TO NEVRO CORP.

SECOND AMENDMENT TO AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT

 

 

IN WITNESS WHEREOF, the parties hereto have duly executed this Second Amendment as of the date first above written.

 

 

	
 
    	
COVIDIEN   GROUP S.A.R.L.
    
	
 
    	
 
    	
 
    
	
 
    	
 
    	
 
    
	
 
    	
     By:
    	
/s/   Michelangelo F. Stefani
    
	
 
    	
     Name:
    	
Michelangelo   F. Stefani
    
	
 
    	
     Title:
    	
General   Manager
    

 

SIGNATURE PAGE TO NEVRO CORP.

SECOND AMENDMENT TO AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT

 

 

IN WITNESS WHEREOF, the parties hereto have duly executed this Second Amendment as of the date first above written.

 

 

	
 
    	
NEA   VENTURES 2013, LIMITED PARTNERSHIP
    
	
 
    	
 
    
	
 
    	
 
    
	
 
    	
     By:
    	
/s/   Louis S. Citron
    
	
 
    	
     Name:
    	
Louis   S. Citron
    
	
 
    	
     Title:
    	
Vice-President
    
	
 
    	
 
    	
 
    
	
 
    	
 
    	
 
    
	
 
    	
NEW   ENTERPRISE ASSOCIATES 14, L.P.
    
	
 
    	
 
    
	
 
    	
By:   NEA Partners 14, L.P.
    
	
 
    	
 
    
	
 
    	
By:   NEA 14 GP, LTD.
    
	
 
    	
 
    	
 
    
	
 
    	
Its:
    	
 
    
	
 
    	
 
    	
 
    
	
 
    	
 
    	
 
    
	
 
    	
     By:
    	
/s/   Louis S. Citron
    
	
 
    	
     Name:
    	
Louis   S. Citron
    
	
 
    	
     Title:
    	
Chief   Legal Officer
    

 

SIGNATURE PAGE TO NEVRO CORP.

SECOND AMENDMENT TO AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT

 

 

IN WITNESS WHEREOF, the parties hereto have duly executed this Second Amendment as of the date first above written.

 

 

	
 
    	
/s/   Andrew Galligan
    
	
 
    	
ANDREW GALLIGAN
    
	
 
    	
 
    
	
 
    	
 
    
	
 
    	
 
    
	
 
    	
ANDRE   WALKER
    

 

SIGNATURE PAGE TO NEVRO CORP.

SECOND AMENDMENT TO AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT

 

 

IN WITNESS WHEREOF, the parties hereto have duly executed this Second Amendment as of the date first above written.

 

 

	
 
    	
/s/   Michael DeMane
    
	
 
    	
MICHAEL DEMANE
    
	
 
    	
 
    
	
 
    	
 
    
	
 
    	
 
    	
THE   MICHAEL F. DEMANE 2012 RETAINED ANNUITY TRUST U/A/D JULY 26, 2012
    
	
 
    	
 
    	
 
    
	
 
    	
 
    	
 
    
	
 
    	
 
    	
By:
    	
/s/   Michael DeMane
    
	
 
    	
 
    	
Name:
    	
Michael   DeMane
    
	
 
    	
 
    	
Title:
    	
Trustee
    
	
 
    	
 
    	
 
    	
 
    
	
 
    	
 
    	
 
    	
 
    
	
 
    	
THE   MICHAEL F. DEMANE 2013 RETAINED ANNUITY TRUST
    
	
 
    	
 
    
	
 
    	
 
    	
 
    
	
 
    	
 
    	
By:
    	
/s/   Michael DeMane
    
	
 
    	
 
    	
Name:
    	
Michael   DeMane
    
	
 
    	
 
    	
Title:
    	
Trustee
    

 

SIGNATURE PAGE TO NEVRO CORP.

SECOND AMENDMENT TO AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00237-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00237-of-00352.parquet"}]]